世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

欧州セルライト治療市場 2023-2030


EUROPE CELLULITE TREATMENT MARKET 2023-2030

市場の展望 Triton Market Researchのレポートでは、ヨーロッパのセルライト治療市場は、予測年2023年から2030年の間に、収益が9.51%の複合年間成長率で進むと予想されているとほのめかしています。ドイツ、イ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Triton Market Research
トリトンマーケットリサーチ
2023年5月2日 US$1,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
121 英語

 

サマリー

市場の展望
Triton Market Researchのレポートでは、ヨーロッパのセルライト治療市場は、予測年2023年から2030年の間に、収益が9.51%の複合年間成長率で進むと予想されているとほのめかしています。ドイツ、イタリア、英国、スペイン、フランス、北欧諸国、および欧州の残りの地域が調査対象です。
フランスでは、人口の約40%が肥満と診断されており、様々な治療法への需要が高まっています。さらに、老人の人口が多いことも特徴です。このため、近年、セルライト減少治療に対するニーズが高まっています。さらに、業界筋によると、形成外科医の利用可能性も過去数年間で増加している。したがって、美意識の高まりにより、皮膚の施術に対する需要が増加し、セルライト治療市場を成長軌道に乗せることが期待されます。
さらに、技術の進歩により美容施術が強化され、イタリアでは様々な消費者を魅了しています。また、革新的な皮膚治療を求める外国人患者の増加も見られます。この点で、高周波療法は大きな注目を浴びています。低侵襲手術の急増は、医療観光客の流入に拍車をかけている。したがって、医療観光客と美容意識の高まりは、イタリア全土のセルライト治療市場に新たな道を開くことになります。

競争展望
セルライト治療市場の注目すべき企業には、ジョンソン・エンド・ジョンソン、Bausch Health Companies Inc、Cutera Inc、Galderma SA、Candela Medical Corporationがあります。


ページTOPに戻る


目次

TABLE OF CONTENTS
1. EUROPE CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.PARENT MARKET ANALYSIS
2.2.IMPACT ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1.COVID-19 IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2.UKRAINE-RUSSIA WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3.PORTER’S FIVE FORCES ANALYSIS
2.3.1.THREAT OF NEW ENTRANTS
2.3.2.THREAT OF SUBSTITUTES
2.3.3.BARGAINING POWER OF BUYERS
2.3.4.BARGAINING POWER OF SUPPLIERS
2.3.5.THREAT OF COMPETITIVE RIVALRY
2.4.MARKET MATURITY ANALYSIS
2.5.INDUSTRY COMPONENTS
2.5.1.RESEARCH AND DEVELOPMENT
2.5.2.MANUFACTURING OF PRODUCT
2.5.3.DISTRIBUTION
2.5.4.POST-SALES MONITORING
2.6.REGULATORY FRAMEWORK
2.7.KEY BUYING IMPACT ANALYSIS
2.7.1.PRICE
2.7.2.BRAND NAME
2.7.3.USABILITY
2.8.KEY MARKET STRATEGIES
2.8.1.COLLABORATIONS
2.8.2.PRODUCT LAUNCHES
2.8.3.MERGERS & ACQUISITIONS
2.8.4.BUSINESS DIVESTITURES & EXPANSIONS
2.9.MARKET DRIVERS
2.9.1.GROWING PREVALENCE OF OBESITY
2.9.2.RAPIDLY GROWING MEDICAL TOURISM SECTOR
2.9.3.RISING DEMAND FOR AESTHETIC PROCEDURES
2.10.MARKET CHALLENGES
2.10.1.LACK OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2.HIGH PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3.RISKS ASSOCIATED POST-TREATMENT
2.11.MARKET OPPORTUNITIES
2.11.1.RISING BEAUTY CONSCIOUSNESS
2.11.2.INCREASING TREND OF ANTI-CELLULITE MASSAGE
2.11.3.GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4.RISING POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5.ADVANCEMENTS IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12.ANALYST PERSPECTIVE
3. EUROPE CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1.SOFT CELLULITE
3.2.HARD CELLULITE
3.3.EDEMATOUS CELLULITE
4. EUROPE CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1.NON-INVASIVE
4.2.MINIMALLY INVASIVE
4.3.TOPICAL
5. EUROPE CELLULITE TREATMENT MARKET – BY END-USER
5.1.HOSPITALS
5.2.CLINICS AND BEAUTY CENTERS
5.3.OTHER END-USERS
6. EUROPE CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1.COUNTRY ANALYSIS
6.1.1.UNITED KINGDOM
6.1.1.1.UNITED KINGDOM CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2.GERMANY
6.1.2.1.GERMANY CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.3.FRANCE
6.1.3.1.FRANCE CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.4.ITALY
6.1.4.1.ITALY CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.5.SPAIN
6.1.5.1.SPAIN CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.6.NORDIC COUNTRIES
6.1.6.1.NORDIC COUNTRIES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.7.REST OF EUROPE
6.1.7.1.REST OF EUROPE CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE LANDSCAPE
7.1.JOHNSON & JOHNSON
7.1.1.OVERVIEW
7.1.2.PRODUCT PORTFOLIO
7.1.3.KEY STRENGTHS
7.1.4.KEY CHALLENGES
7.2.ABBVIE INC
7.2.1.OVERVIEW
7.2.2.PRODUCT PORTFOLIO
7.2.3.KEY STRENGTHS
7.2.4.KEY CHALLENGES
7.3.BAUSCH HEALTH COMPANIES INC
7.3.1.OVERVIEW
7.3.2.PRODUCT PORTFOLIO
7.3.3.KEY STRENGTHS
7.3.4.KEY CHALLENGES
7.4.CUTERA INC
7.4.1.OVERVIEW
7.4.2.PRODUCT PORTFOLIO
7.4.3.KEY STRENGTHS
7.4.4.KEY CHALLENGES
7.5.INCELER MEDIKAL
7.5.1.OVERVIEW
7.5.2.PRODUCT PORTFOLIO
7.5.3.KEY STRENGTHS
7.5.4.KEY CHALLENGES
7.6.ZIMMER MEDIZINSYSTEME GMBH
7.6.1.OVERVIEW
7.6.2.PRODUCT PORTFOLIO
7.6.3.KEY STRENGTHS
7.6.4.KEY CHALLENGES
7.7.GALDERMA SA
7.7.1.OVERVIEW
7.7.2.PRODUCT PORTFOLIO
7.7.3.KEY STRENGTHS
7.7.4.KEY CHALLENGES
7.8.SIENTRA INC
7.8.1.OVERVIEW
7.8.2.PRODUCT PORTFOLIO
7.8.3.KEY STRENGTHS
7.8.4.KEY CHALLENGES
7.9.ENDO INTERNATIONAL PLC
7.9.1.OVERVIEW
7.9.2.PRODUCT PORTFOLIO
7.9.3.KEY STRENGTHS
7.9.4.KEY CHALLENGES
7.10.CANDELA MEDICAL CORPORATION
7.10.1.OVERVIEW
7.10.2.PRODUCT PORTFOLIO
7.10.3.KEY STRENGTHS
7.10.4.KEY CHALLENGES
8. RESEARCH METHODOLOGY & SCOPE
8.1.RESEARCH SCOPE & DELIVERABLES
8.1.1.OBJECTIVES OF STUDY
8.1.2.SCOPE OF STUDY
8.2.SOURCES OF DATA
8.2.1.PRIMARY DATA SOURCES
8.2.2.SECONDARY DATA SOURCES
8.3.RESEARCH METHODOLOGY
8.3.1.EVALUATION OF THE PROPOSED MARKET
8.3.2.IDENTIFICATION OF DATA SOURCES
8.3.3.ASSESSMENT OF MARKET DETERMINANTS
8.3.4.DATA COLLECTION
8.3.5.DATA VALIDATION & ANALYSIS

TABLE LIST
TABLE 1: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: EUROPE CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

FIGURE LIST
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: EUROPE CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: EUROPE CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: EUROPE CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: EUROPE CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: EUROPE CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: EUROPE CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: EUROPE CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: EUROPE CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)
FIGURE 14: EUROPE CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: EUROPE CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: UNITED KINGDOM CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: GERMANY CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: FRANCE CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: ITALY CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: SPAIN CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: NORDIC COUNTRIES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 22: REST OF EUROPE CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)

ページTOPに戻る



図表リスト

TABLE LIST
TABLE 1: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: EUROPE CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

 

ページTOPに戻る


 

Summary

MARKET OUTLOOK
Triton Market Research’s report insinuates that the cellulite treatment market in Europe is expected to advance with a compound annual growth rate of 9.51% in revenue during forecast years 2023-2030. Germany, Italy, the United Kingdom, Spain, France, Nordic Countries, and the Rest of Europe are studied in the region.
In France, about 40% of the population is diagnosed with obesity, which has elevated the demand for various treatments. Moreover, there is a high population base of geriatric population. This has increased the need for cellulite reduction treatments over recent years. Further, as per industry sources, the availability of plastic surgeons has also increased over the past few years. Hence, the rising beauty consciousness is expected to increase the demand for skin procedures, thereby driving the cellulite treatment market on a growth path.
Furthermore, technological advancements have enhanced aesthetic procedures, attracting various consumers in Italy. There is also a rise in foreign patients seeking innovative skin treatments. In this regard, radiofrequency therapy has gained significant prominence. The surge in minimally invasive procedures has fueled an influx of medical tourists. Therefore, the rise in medical tourists and beauty consciousness opens new avenues for the cellulite treatment market across Italy.

COMPETITIVE OUTLOOK
The notable companies in the cellulite treatment market include Johnson & Johnson, Bausch Health Companies Inc, Cutera Inc, Galderma SA, and Candela Medical Corporation.



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1. EUROPE CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1.PARENT MARKET ANALYSIS
2.2.IMPACT ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1.COVID-19 IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2.UKRAINE-RUSSIA WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3.PORTER’S FIVE FORCES ANALYSIS
2.3.1.THREAT OF NEW ENTRANTS
2.3.2.THREAT OF SUBSTITUTES
2.3.3.BARGAINING POWER OF BUYERS
2.3.4.BARGAINING POWER OF SUPPLIERS
2.3.5.THREAT OF COMPETITIVE RIVALRY
2.4.MARKET MATURITY ANALYSIS
2.5.INDUSTRY COMPONENTS
2.5.1.RESEARCH AND DEVELOPMENT
2.5.2.MANUFACTURING OF PRODUCT
2.5.3.DISTRIBUTION
2.5.4.POST-SALES MONITORING
2.6.REGULATORY FRAMEWORK
2.7.KEY BUYING IMPACT ANALYSIS
2.7.1.PRICE
2.7.2.BRAND NAME
2.7.3.USABILITY
2.8.KEY MARKET STRATEGIES
2.8.1.COLLABORATIONS
2.8.2.PRODUCT LAUNCHES
2.8.3.MERGERS & ACQUISITIONS
2.8.4.BUSINESS DIVESTITURES & EXPANSIONS
2.9.MARKET DRIVERS
2.9.1.GROWING PREVALENCE OF OBESITY
2.9.2.RAPIDLY GROWING MEDICAL TOURISM SECTOR
2.9.3.RISING DEMAND FOR AESTHETIC PROCEDURES
2.10.MARKET CHALLENGES
2.10.1.LACK OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2.HIGH PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3.RISKS ASSOCIATED POST-TREATMENT
2.11.MARKET OPPORTUNITIES
2.11.1.RISING BEAUTY CONSCIOUSNESS
2.11.2.INCREASING TREND OF ANTI-CELLULITE MASSAGE
2.11.3.GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4.RISING POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5.ADVANCEMENTS IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12.ANALYST PERSPECTIVE
3. EUROPE CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1.SOFT CELLULITE
3.2.HARD CELLULITE
3.3.EDEMATOUS CELLULITE
4. EUROPE CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1.NON-INVASIVE
4.2.MINIMALLY INVASIVE
4.3.TOPICAL
5. EUROPE CELLULITE TREATMENT MARKET – BY END-USER
5.1.HOSPITALS
5.2.CLINICS AND BEAUTY CENTERS
5.3.OTHER END-USERS
6. EUROPE CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1.COUNTRY ANALYSIS
6.1.1.UNITED KINGDOM
6.1.1.1.UNITED KINGDOM CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2.GERMANY
6.1.2.1.GERMANY CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.3.FRANCE
6.1.3.1.FRANCE CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.4.ITALY
6.1.4.1.ITALY CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.5.SPAIN
6.1.5.1.SPAIN CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.6.NORDIC COUNTRIES
6.1.6.1.NORDIC COUNTRIES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.7.REST OF EUROPE
6.1.7.1.REST OF EUROPE CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE LANDSCAPE
7.1.JOHNSON & JOHNSON
7.1.1.OVERVIEW
7.1.2.PRODUCT PORTFOLIO
7.1.3.KEY STRENGTHS
7.1.4.KEY CHALLENGES
7.2.ABBVIE INC
7.2.1.OVERVIEW
7.2.2.PRODUCT PORTFOLIO
7.2.3.KEY STRENGTHS
7.2.4.KEY CHALLENGES
7.3.BAUSCH HEALTH COMPANIES INC
7.3.1.OVERVIEW
7.3.2.PRODUCT PORTFOLIO
7.3.3.KEY STRENGTHS
7.3.4.KEY CHALLENGES
7.4.CUTERA INC
7.4.1.OVERVIEW
7.4.2.PRODUCT PORTFOLIO
7.4.3.KEY STRENGTHS
7.4.4.KEY CHALLENGES
7.5.INCELER MEDIKAL
7.5.1.OVERVIEW
7.5.2.PRODUCT PORTFOLIO
7.5.3.KEY STRENGTHS
7.5.4.KEY CHALLENGES
7.6.ZIMMER MEDIZINSYSTEME GMBH
7.6.1.OVERVIEW
7.6.2.PRODUCT PORTFOLIO
7.6.3.KEY STRENGTHS
7.6.4.KEY CHALLENGES
7.7.GALDERMA SA
7.7.1.OVERVIEW
7.7.2.PRODUCT PORTFOLIO
7.7.3.KEY STRENGTHS
7.7.4.KEY CHALLENGES
7.8.SIENTRA INC
7.8.1.OVERVIEW
7.8.2.PRODUCT PORTFOLIO
7.8.3.KEY STRENGTHS
7.8.4.KEY CHALLENGES
7.9.ENDO INTERNATIONAL PLC
7.9.1.OVERVIEW
7.9.2.PRODUCT PORTFOLIO
7.9.3.KEY STRENGTHS
7.9.4.KEY CHALLENGES
7.10.CANDELA MEDICAL CORPORATION
7.10.1.OVERVIEW
7.10.2.PRODUCT PORTFOLIO
7.10.3.KEY STRENGTHS
7.10.4.KEY CHALLENGES
8. RESEARCH METHODOLOGY & SCOPE
8.1.RESEARCH SCOPE & DELIVERABLES
8.1.1.OBJECTIVES OF STUDY
8.1.2.SCOPE OF STUDY
8.2.SOURCES OF DATA
8.2.1.PRIMARY DATA SOURCES
8.2.2.SECONDARY DATA SOURCES
8.3.RESEARCH METHODOLOGY
8.3.1.EVALUATION OF THE PROPOSED MARKET
8.3.2.IDENTIFICATION OF DATA SOURCES
8.3.3.ASSESSMENT OF MARKET DETERMINANTS
8.3.4.DATA COLLECTION
8.3.5.DATA VALIDATION & ANALYSIS

TABLE LIST
TABLE 1: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: EUROPE CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

FIGURE LIST
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: EUROPE CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: EUROPE CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: EUROPE CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: EUROPE CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: EUROPE CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: EUROPE CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: EUROPE CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: EUROPE CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)
FIGURE 14: EUROPE CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: EUROPE CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: UNITED KINGDOM CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: GERMANY CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: FRANCE CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: ITALY CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 20: SPAIN CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 21: NORDIC COUNTRIES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 22: REST OF EUROPE CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)

ページTOPに戻る



List of Tables/Graphs

TABLE LIST
TABLE 1: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: EUROPE CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: EUROPE CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: EUROPE CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Triton Market Research社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Triton Market Research社はどのような調査会社ですか?


Triton Market Researchはヘルスケア、オートメーション、ICT技術、農産業、建設など幅広い産業を対象にした調査およびレポート出版を行っています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る